Clinical trial
Effect of Antacids on Gleevec® in Healthy Volunteers
NCT00446316 · University of Pittsburgh, Other · Completed
Key facts
| NCT number | NCT00446316 |
|---|---|
| Title | Effect of Antacids on Gleevec® in Healthy Volunteers |
| Official title | Effect of Antacids (Mg-Al-based) on Imatinib Mesylate (Gleevec®) Pharmacokinetics in Healthy Volunteers (CSTI571BUS257) |
| Lead sponsor | University of Pittsburgh, Other |
| Collaborators | Novartis Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Healthy |
| Intervention type | Drug |
| Interventions | Antacids (Mg-Al-based), Imatimib Mesylate (Gleevec®) |
| Enrollment | 12 |
| Start date | Apr 1, 2007 |
| Primary completion | Oct 1, 2008 |
| Completion | Oct 1, 2008 |
| First posted | Mar 12, 2007 |
| Last update posted | Jun 22, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: